Risky business? Outcomes of lap appy in patients on antithrombotic therapy

Presented by Christopher Pearcy, MD at the SS21: Acute Care Surgery held during the 2017 SAGES Annual Meeting in Houston, TX on Friday, March 24, 2017

Keyword(s): abdominal pain, abdominal surgery, acute care surgery, age, antibiotics, antiplatelet, antithrombotic therapy, Apixaban, appendicitis, aspirin, bleeding, blood loss, comorbidities, complications, coronary artery disease, diabetes, EBL, elderly, Eliquis, estimated blood loss, gender, IAT therapy, infection, lap appy, laparoscopic appendectomy, male, medication, mortality, non-operative therapy, null hypothesis, outcomes, Plavix, polypharmacy, primary outcomes, readmission, right lower quadrant, risk benefit analysis, RLQ, SSI, stroke, surgical site infection, transfusion, urgent laparoscopic appendectomy

Objective–34 sec

Background–46 sec

Clinical case–1:20

Methods–2:26

Inclusion/exclusion criteria–2:42

Study design–3:06

Results–4:04

Summary–4:45

Conclusion–4:59

References–5:13 Am J Epidemiol 1990

Best Pract Res Clin Gastroenterol 2006

Isr Med Assoc J 2011